Dabigatran Etexilate

Back to search

Molecule Structure

Scientific Name

Dabigatran Etexilate

Description of the Drug

Dabigatran etexilate is an anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06695

Brand Name(s)

Pradaxa

Company Owner(s)

Boehringer Ingelheim Pharmaceuticals Inc, Alkem Laboratories Ltd, Hetero Labs Ltd Unit Iii

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Thrombin SINGLE PROTEIN INHIBITOR CHEMBL204

Unichem Links

SureChEMBL SCHEMBL505829
PharmGKB PA165958369
Human Metabolome Database HMDB0015641
DrugBank DB06695
PubChem: Thomson Pharma 17383903 14814262 49701786
PubChem 6445226 213023 135565674 9578572
LINCS LSM-45249
Nikkaji J2.566.951G
BindingDB 50432209
EPA CompTox Dashboard DTXSID4057681
DrugCentral 776
Brenda 40386 167472
Guide to Pharmacology 6379
rxnorm DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE MESYLATE PRADAXA
ChEBI 70746
ZINC ZINC000003943279